ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 545

Preferential Infiltration Of Double-Negative (DN) T Cells Into The Glomeruli Of NZM 2328 Lupus Mice

Ning Yu, Shunhua Guo, William Stohl and Chaim O. Jacob, Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: animal models and glomerulonephritis, Lupus, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Lupus nephritis affects at least 50% of patients with SLE and is a major cause of morbidity. The pathologic picture of lupus nephritis is complex and the precise mechanisms that underlie the development of lupus nephritis remain unclear.  The present study was undertaken to delineate the differential localization of lymphocytes infiltrating the glomeruli versus the tubulo-interstitium in NZM 2328 mice, a murine model that closely mimics human lupus nephritis.

Methods: Kidneys were evaluated by in situ histology  and immunohistochemistry. Cells infiltrating the glomeruli were separated from those infiltrating the tubulo-interstitium through  enzymatic, magnetic, and mechanical procedures and were characterized by flow cytometry.

Results: B cells and macrophages each represent ~5% of the cells infiltrating both the glomeruli and tubulo-interstitium, whereas CD3+ T cells represent 40-60% and 70-80% of the infiltrating cells, respectively. In the tubulo-interstitium, 50-60% of CD3+ T cells are CD4+, 15-25% are CD8+, and 20-30% are DN. In contrast, the T cells infiltrating the glomeruli are only 1-5% CD4+ cells and <1% CD8+ cells, whereas 95-98% are DN. Furthermore, most of the T cells infiltrating the glomeruli display an activated memory phenotype (CD62Lneg, CD44high, CD69+). About 20-25% of these activated T cells are also CD1d tetramer positive, indicative of an iNKT cell phenotype. A significant difference in the abundance of NK1.1+ cells was also observed. Among cells infiltrating the glomeruli, 20-35% are NK1.1+ , whereas only 3-10% of the cells infiltrating the tubulo-interstitium are NK1.1+ . These data are highly relevant in comparison with the composition of T cells in the spleen of NZM 2328 mice. The activated memory T cell subset serves as a major biological surrogate marker of clinical disease progression.  As determined by gene-array analysis, these activated memory T cells display neither a Th1 nor Th2 profile but rather express a Th17 profile and produce IL-17. Most importantly, these activated memory cells progressively increase in numbers during disease development, not only in the spleen, but  in the kidney as well. However, during migration of these cells from the periphery to the kidney and especially into the glomeruli, they lose their CD4+ expression and become mostly DN.

Conclusion: The present study is, to our knowledge, the first direct and detailed analysis of the immune infiltrates in the glomeruli and the tubulo-interstitium in lupus kidneys. The identification of DN T cells bearing an activated memory phenotype as the major cell population in the glomeruli of clinically nephritic mice is likely highly relevant to the pathogenesis of human lupus nephritis. Given that DN T cells are found in kidney biopsies of patients with lupus nephritis and these cells are capable of producing IL-17, our results further support this subset of cells as contributory to development of kidney damage.


Disclosure:

N. Yu,
None;

S. Guo,
None;

W. Stohl,
None;

C. O. Jacob,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/preferential-infiltration-of-double-negative-dn-t-cells-into-the-glomeruli-of-nzm-2328-lupus-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology